
Overview
Hetalox is a company that offers artificial intelligence (AI) solutions for the advanced assessment and analysis of brain MRI studies, specifically aimed at monitoring the progression of neurodegenerative and demyelinating diseases such as dementia and multiple sclerosis. Their services include early disease detection, monitoring disease progression, and supporting treatment decisions to improve patient quality of life.
Financials
Revenue history
From the notes
| Loans and borrowings | $42,833 |
Filing timeliness
The financial statement for 2024 was filed on time.
- 2025filed
- 202415/07/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

Hetalox Secures 2nd Place at the MIT GSW 2025 Pitching Competition!
We assist in monitoring the progression of neurodegenerative and demyelinating diseases. We offer artificial intelligence (AI) solutions for advanced assessment and analysis of brain MRI studies.

We begin acceleration in the Startup Booster for Social Impact program
In cooperation with 24ventures fund and mentors we are going to conduct pilot studies that will verify the effectiveness of the platform in clinical conditions and more.

Hetalox at the 6th Saxon-Polish Innovation Day
We were honored to participate in the 6th Saxon-Polish Days, where Hetalox was proudly represented by our team

Hetalox at Made in Wrocław 2024
Hetalox participated in VC Demo Day during the Made in Wrocław 2024 event, showcasing our AI-driven solutions for medical imaging.

Our workshop at MICCAI 2024
We had an incredible time at the MICCAI 2024 Conference during the CLINICCAI (Clinical Translation of Medical Image Computing and Computer-Assisted Interventions), where we had the pleasure to present the work with significant contributions from Hetalox.
Industry
Offer
- Brain MRI image analysis
- Software for assessing MRI scans
- Monitoring of neurodegenerative diseases
Websites
- hetalox.comHetalox — We assist in monitoring the progression of neurodegenerative and demyelinating diseases.
Job offers
The company has its own careers page: hetalox.com/careers.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 436 | $5,888.71 | 54.5% | |
Adrian Korbecki age 34 | 364 | $4,916.26 | 45.5% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 18, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $100.4K$100,448 | Uniwersytet SWPS |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Svexa Poland sp. z o.o. | $50,582.53 | svexa.com | ||
| Muotech sp. z o.o. | $21,191.78 | muotech.io | ||
| OWL Iot sp. z o.o. | $13,561.02 | owliot.pl | ||
| Skinai sp. z o.o. | $11,914.59 | skinai.pl | ||
| Meetrigo sp. z o.o. | $7,154.27 | meetrigo.com | ||
| Trainai sp. z o.o. | $5,521.94 | trainai.io | ||
| ZDRO Tech sp. z o.o. | $4,137.92 | zdro.tech | ||
| Medbot sp. z o.o. | $1,994.73 | medbot.pl | ||
| Narmox sp. z o.o. | $1,946.87 | narmox.com | ||
| Neurospace sp. z o.o. | $678.93 | neurospace.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-06-24 | Share capital increase (5,000.00 PLN → 40,000.00 PLN) | |
| 2024-01-05 | Entered in the register |
FAQ
Last updated: 2026-10-07
